Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Research

Assessing the relationship between multimorbidity, NCD configurations, frailty phenotypes, and mortality risk in older adults

Authors: Rafael Ogaz-González, Eva Corpeleijn, Rosa Estela García-Chanes, Luis Miguel Gutierréz-Robledo, Ricardo Antonio Escamilla-Santiago, Malaquías López-Cervantes

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

Older adults are increasingly susceptible to prolonged illness, multiple chronic diseases, and disabilities, which can lead to the coexistence of multimorbidity and frailty. Multimorbidity may result in various noncommunicable disease (NCD) patterns or configurations that could be associated with frailty and death. Mortality risk may vary depending on the presence of specific chronic diseases configurations or frailty.

Methods

The aim was to examine the impact of NCD configurations on mortality risk among older adults with distinct frailty phenotypes. The population was analyzed from the Costa Rican Longevity and Healthy Aging Study Cohort (CRELES). A total of 2,662 adults aged 60 or older were included and followed for 5 years. Exploratory factor analysis and various clustering techniques were utilized to identify NCD configurations. The frequency of NCD accumulation was also assessed for a multimorbidity definition. Frailty phenotypes were set according to Fried et al. criteria. Kaplan‒Meier survival analyses, mortality rates, and Cox proportional hazards models were estimated.

Results

Four different types of patterns were identified: ‘Neuro-psychiatric’, ‘Metabolic’, ‘Cardiovascular’, and ‘Mixt’ configurations. These configurations showed a higher mortality risk than the mere accumulation of NCDs [Cardiovascular HR:1.65 (1.07–2.57); ‘Mixt’ HR:1.49 (1.00-2.22); ≥3 NCDs HR:1.31 (1.09–1.58)]. Frailty exhibited a high and constant mortality risk, irrespective of the presence of any NCD configuration or multimorbidity definition. However, HRs decreased and lost statistical significance when phenotypes were considered in the Cox models [frailty + ‘Cardiovascular’ HR:1.56 (1.00-2.42); frailty + ‘Mixt’:1.42 (0.95–2.11); and frailty + ≥ 3 NCDs HR:1.23 (1.02–1.49)].

Conclusions

Frailty accompanying multimorbidity emerges as a more crucial indicator of mortality risk than multimorbidity alone. Therefore, studying NCD configurations is worthwhile as they may offer improved risk profiles for mortality as alternatives to straightforward counts.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hogan DB. Models, definitions, and criteria for frailty. In: Ram JL, Conn PM, editors. Conn’s handbook of models for human aging. Academic; 2018. pp. 35–44. Hogan DB. Models, definitions, and criteria for frailty. In: Ram JL, Conn PM, editors. Conn’s handbook of models for human aging. Academic; 2018. pp. 35–44.
2.
go back to reference Brivio P, Paladini MS, Racagni G, Riva MA, Calabrese F, Molteni R. From healthy aging to frailty: in search of the underlying mechanisms. Curr Med Chem. 2019;26(20):3685–701.CrossRefPubMed Brivio P, Paladini MS, Racagni G, Riva MA, Calabrese F, Molteni R. From healthy aging to frailty: in search of the underlying mechanisms. Curr Med Chem. 2019;26(20):3685–701.CrossRefPubMed
3.
go back to reference Xia S, Zhang X, Zheng S, Khanabdali R, Kalionis B, Wu J et al. An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res. 2016;2016. Xia S, Zhang X, Zheng S, Khanabdali R, Kalionis B, Wu J et al. An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res. 2016;2016.
4.
go back to reference Dodig S, Čepelak I, Pavić I. Hallmarks of senescence and aging. Biochem Med (Zagreb). 2019;29(3). Dodig S, Čepelak I, Pavić I. Hallmarks of senescence and aging. Biochem Med (Zagreb). 2019;29(3).
5.
6.
go back to reference Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: systematic literature review and meta-analysis. Ageing Res Rev. 2019;53:100903.CrossRefPubMed Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: systematic literature review and meta-analysis. Ageing Res Rev. 2019;53:100903.CrossRefPubMed
7.
go back to reference Bloom DE, Boersch-Supan A, Mcgee P, Seike A. Population aging: facts, challenges, and responses. cdn1.sph.harvard.edu. 2011. Bloom DE, Boersch-Supan A, Mcgee P, Seike A. Population aging: facts, challenges, and responses. cdn1.sph.harvard.edu. 2011.
8.
go back to reference Wleklik M, Uchmanowicz I, Jankowska EA, Vitale C, Lisiak M, Drozd M, et al. Multidimensional approach to frailty. Front Psychol. 2020;11:517603.CrossRef Wleklik M, Uchmanowicz I, Jankowska EA, Vitale C, Lisiak M, Drozd M, et al. Multidimensional approach to frailty. Front Psychol. 2020;11:517603.CrossRef
9.
10.
go back to reference Ferrucci L, Gonzalez-Freire M, Fabbri E, Simonsick E, Tanaka T, Moore Z et al. Measuring biological aging in humans: a quest. Aging Cell. 2020;19(2). Ferrucci L, Gonzalez-Freire M, Fabbri E, Simonsick E, Tanaka T, Moore Z et al. Measuring biological aging in humans: a quest. Aging Cell. 2020;19(2).
12.
go back to reference Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, Lingner H, et al. The European general practice research network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013;14(5):319–25.CrossRefPubMed Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, Lingner H, et al. The European general practice research network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013;14(5):319–25.CrossRefPubMed
13.
go back to reference Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, Van Den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67(3):254–66.CrossRefPubMed Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, Van Den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67(3):254–66.CrossRefPubMed
17.
go back to reference Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023;57. Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023;57.
18.
go back to reference World Health Organization. Noncommunicable diseases country profiles 2018. 2018. World Health Organization. Noncommunicable diseases country profiles 2018. 2018.
19.
go back to reference Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. 2018;392(10152):1072–88.CrossRef Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. 2018;392(10152):1072–88.CrossRef
20.
go back to reference Kanesarajah J, Waller M, Whitty JA, Mishra GD. Multimorbidity and quality of life at mid-life: a systematic review of general population studies. Maturitas. 2018;109:53–62.CrossRefPubMed Kanesarajah J, Waller M, Whitty JA, Mishra GD. Multimorbidity and quality of life at mid-life: a systematic review of general population studies. Maturitas. 2018;109:53–62.CrossRefPubMed
21.
go back to reference Sum G, Salisbury C, Koh GCH, Atun R, Oldenburg B, Mcpake B et al. Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis. J Glob Health. 2019;9(2). Sum G, Salisbury C, Koh GCH, Atun R, Oldenburg B, Mcpake B et al. Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis. J Glob Health. 2019;9(2).
22.
go back to reference Ferrer A, Formiga F, Sanz H, Almeda J, Padrós G. Multimorbidity as specific disease combinations, an important predictor factor for mortality in octogenarians: the Octabaix study. Clin Interv Aging. 2017;12:223.CrossRefPubMedPubMedCentral Ferrer A, Formiga F, Sanz H, Almeda J, Padrós G. Multimorbidity as specific disease combinations, an important predictor factor for mortality in octogenarians: the Octabaix study. Clin Interv Aging. 2017;12:223.CrossRefPubMedPubMedCentral
24.
go back to reference Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.CrossRefPubMed Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.CrossRefPubMed
26.
go back to reference Rodríguez-Laso Á, Caballero Mora MÁ, García Sánchez I, Alonso Bouzón C, Rodríguez Mañas L, Bernabei R, et al. Updated state of the art report on the prevention and management of frailty. European Union; 2019. Rodríguez-Laso Á, Caballero Mora MÁ, García Sánchez I, Alonso Bouzón C, Rodríguez Mañas L, Bernabei R, et al. Updated state of the art report on the prevention and management of frailty. European Union; 2019.
27.
go back to reference O’Caoimh R, Sezgin D, O’Donovan MR, William Molloy D, Clegg A, Rockwood K, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50(1):96–104.CrossRefPubMed O’Caoimh R, Sezgin D, O’Donovan MR, William Molloy D, Clegg A, Rockwood K, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50(1):96–104.CrossRefPubMed
28.
go back to reference Nguyen QD, Wu C, Odden MC, Kim DH. Multimorbidity patterns, frailty, and survival in community-dwelling older adults. Journals Gerontology: Ser A. 2019;74(8):1265–70. Nguyen QD, Wu C, Odden MC, Kim DH. Multimorbidity patterns, frailty, and survival in community-dwelling older adults. Journals Gerontology: Ser A. 2019;74(8):1265–70.
30.
go back to reference Juul-Larsen HG, Christensen LD, Bandholm T, Andersen O, Kallemose T, Jørgensen LM, et al. Patterns of multimorbidity and differences in healthcare utilization and complexity among acutely hospitalized medical patients (≥ 65 years)– a latent class approach. Clin Epidemiol. 2020;12:245.CrossRefPubMedPubMedCentral Juul-Larsen HG, Christensen LD, Bandholm T, Andersen O, Kallemose T, Jørgensen LM, et al. Patterns of multimorbidity and differences in healthcare utilization and complexity among acutely hospitalized medical patients (≥ 65 years)– a latent class approach. Clin Epidemiol. 2020;12:245.CrossRefPubMedPubMedCentral
33.
go back to reference Vetrano DL, Calderón-Larrañaga A, Marengoni A, Onder G, Bauer JM, Cesari M, et al. An international perspective on chronic multimorbidity: approaching the elephant in the room. Journals Gerontology: Ser A. 2018;73(10):1350–6. Vetrano DL, Calderón-Larrañaga A, Marengoni A, Onder G, Bauer JM, Cesari M, et al. An international perspective on chronic multimorbidity: approaching the elephant in the room. Journals Gerontology: Ser A. 2018;73(10):1350–6.
34.
go back to reference Rosero-Bixby L, Fernández X, Dow WH. CRELES: Costa Rican longevity and healthy aging study, 2005 (Costa Rica Estudio de Longevidad y Envejecimiento Saludable). Inter-university Consortium for Political and Social Research [distributor]. NACDA: National Archive of Computerized Data on Aging; 2013 [cited 2023 Aug 24]. https://repository.synchros.eu/study/creles Rosero-Bixby L, Fernández X, Dow WH. CRELES: Costa Rican longevity and healthy aging study, 2005 (Costa Rica Estudio de Longevidad y Envejecimiento Saludable). Inter-university Consortium for Political and Social Research [distributor]. NACDA: National Archive of Computerized Data on Aging; 2013 [cited 2023 Aug 24]. https://​repository.​synchros.​eu/​study/​creles
35.
go back to reference Méndez Chacón E, Rosero Bixby L. Prevalencia De hipertensión en adultos mayores de Costa Rica. Poblac Salud Mesoam. 2007;5(1):1–9. Méndez Chacón E, Rosero Bixby L. Prevalencia De hipertensión en adultos mayores de Costa Rica. Poblac Salud Mesoam. 2007;5(1):1–9.
36.
go back to reference Brenes Camacho G, Rosero-Bixby L. Diabetes mellitus en adultos mayores costarricenses. Poblac Salud Mesoam. 2007;5(1). Brenes Camacho G, Rosero-Bixby L. Diabetes mellitus en adultos mayores costarricenses. Poblac Salud Mesoam. 2007;5(1).
37.
go back to reference Burki T. European commission classifies obesity as a chronic disease. Lancet Diabetes Endocrinol. 2021;9(7):418.CrossRefPubMed Burki T. European commission classifies obesity as a chronic disease. Lancet Diabetes Endocrinol. 2021;9(7):418.CrossRefPubMed
38.
go back to reference Rosero-Bixby L, Dow WH, Brenes G. Costa Rican longevity and healthy aging study. Encyclopedia Gerontol Popul Aging. 2019:1–5. Rosero-Bixby L, Dow WH, Brenes G. Costa Rican longevity and healthy aging study. Encyclopedia Gerontol Popul Aging. 2019:1–5.
39.
go back to reference Alden D, Austin C, Sturgeon R. A correlation between the geriatric depression scale long and short forms. J Gerontol. 1989;44(4):P124–5.CrossRefPubMed Alden D, Austin C, Sturgeon R. A correlation between the geriatric depression scale long and short forms. J Gerontol. 1989;44(4):P124–5.CrossRefPubMed
40.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–57.CrossRef Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–57.CrossRef
41.
go back to reference Rosero Bixby L, Dow WH, Brenes Camacho G. Costa Rican longevity and healthy aging study. 2019. Rosero Bixby L, Dow WH, Brenes Camacho G. Costa Rican longevity and healthy aging study. 2019.
42.
go back to reference Gómez Melis G, Cadarso-Suárez C. El Modelo De Riesgos Proporcionales De Cox Y sus extensiones. Impacto en estadística y biomedicina - dialnet. Gaceta De La Real Sociedad Matemática Española. 2017;20(3):513–38. Gómez Melis G, Cadarso-Suárez C. El Modelo De Riesgos Proporcionales De Cox Y sus extensiones. Impacto en estadística y biomedicina - dialnet. Gaceta De La Real Sociedad Matemática Española. 2017;20(3):513–38.
43.
go back to reference Ng SK, Tawiah R, Sawyer M, Scuffham P. Patterns of multimorbid health conditions: a systematic review of analytical methods and comparison analysis. Int J Epidemiol. 2018;47(5):1687–704.CrossRefPubMed Ng SK, Tawiah R, Sawyer M, Scuffham P. Patterns of multimorbid health conditions: a systematic review of analytical methods and comparison analysis. Int J Epidemiol. 2018;47(5):1687–704.CrossRefPubMed
44.
go back to reference Oude Voshaar RC, Jeuring HW, Borges MK, van den Brink RHS, Marijnissen RM, Hoogendijk EO et al. Course of frailty stratified by physical and mental multimorbidity patterns: a 5-year follow-up of 92,640 participants of the lifelines cohort study. BMC Med. 2021;19(1). Oude Voshaar RC, Jeuring HW, Borges MK, van den Brink RHS, Marijnissen RM, Hoogendijk EO et al. Course of frailty stratified by physical and mental multimorbidity patterns: a 5-year follow-up of 92,640 participants of the lifelines cohort study. BMC Med. 2021;19(1).
45.
go back to reference MacRae C, McMinn M, Mercer SW, Henderson D, McAllister DA, Ho I et al. The impact of varying the number and selection of conditions on estimated multimorbidity prevalence: a cross-sectional study using a large, primary care population dataset. PLoS Med. 2023 [cited 2024 Jan 17];20(4). https://pubmed.ncbi.nlm.nih.gov/37014910/ MacRae C, McMinn M, Mercer SW, Henderson D, McAllister DA, Ho I et al. The impact of varying the number and selection of conditions on estimated multimorbidity prevalence: a cross-sectional study using a large, primary care population dataset. PLoS Med. 2023 [cited 2024 Jan 17];20(4). https://​pubmed.​ncbi.​nlm.​nih.​gov/​37014910/​
46.
go back to reference Wister AV, Multimorbidity Resilience. Conceptual, theoretical, and measurement developments. Resil Aging. 2020:81–105. Wister AV, Multimorbidity Resilience. Conceptual, theoretical, and measurement developments. Resil Aging. 2020:81–105.
49.
go back to reference Rosero-Bixby L, Dow WH. Surprising SES gradients in mortality, health, and biomarkers in a latin American population of adults. J Gerontol B Psychol Sci Soc Sci. 2009;64(1):105–17.CrossRefPubMed Rosero-Bixby L, Dow WH. Surprising SES gradients in mortality, health, and biomarkers in a latin American population of adults. J Gerontol B Psychol Sci Soc Sci. 2009;64(1):105–17.CrossRefPubMed
Metadata
Title
Assessing the relationship between multimorbidity, NCD configurations, frailty phenotypes, and mortality risk in older adults
Authors
Rafael Ogaz-González
Eva Corpeleijn
Rosa Estela García-Chanes
Luis Miguel Gutierréz-Robledo
Ricardo Antonio Escamilla-Santiago
Malaquías López-Cervantes
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04948-9

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.